Finepoint Capital LP

Fundamental concentrated ★Highest signal consumer_discretionary specialist (65%) CIK 1608126
League rank
#19
in Fundamental concentrated · #27 overall
Long book
$417.1M
Q1 2026
Positions
6
Top-10 weight
100%
concentration
Last quarter
+18.2%
SPY +14.8%
Turnover
14%
of book per quarter

Strategy in plain words

auto-generated from filings

Finepoint Capital LP is a concentrated fundamental stock-picker, specialised in consumer_discretionary (65% of the long book), running a $417.1M US long book across 6 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: QXO INC, RXO INC, ALEANNA INC - CL A - 29, ALEANNA INC, MONEYHERO LTD-28.

Over the last 9 quarters its long book ran on average 0.9pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-10.0%
Q2 2024
+21.1%
Q3 2024
-0.5%
Q4 2024
-11.9%
Q1 2025
+40.9%
Q2 2025
-11.1%
Q3 2025
-2.8%
Q4 2025
+4.3%
Q1 2026
+18.2%

Sector allocation

Consumer discretionary
65%
Industrials
35%
Energy
0%
Healthcare
0%

Long book by quarter

$376.5M
Q1 2024
$352.3M
Q2 2024
$822.3M
Q3 2024
$866.9M
Q4 2024
$592.8M
Q1 2025
$504.3M
Q2 2025
$543.0M
Q3 2025
$532.8M
Q4 2025
$417.1M
Q1 2026

What does Finepoint Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
QXO QXO INCConsumer discretionary13.9M$269.1M64.5%-34.6%
RXO RXO INCIndustrials10.1M$147.3M35.3%+7.3%
ANNA ALEANNA INCEnergy27.7K$230K0.1%Held
CLDI CALIDI BIOTHERAPEUTICS INCHealthcare1.0K$2490.0%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 14, 20269$1.95B canonicalSEC ↗
Q4 202513F-HRFeb 13, 20269$2.00B canonicalSEC ↗
Q3 202513F-HRNov 13, 20259$1.74B canonicalSEC ↗
Q2 202513F-HRAug 13, 202510$1.36B canonicalSEC ↗
Q1 202513F-HRMay 14, 202525$1.31B canonicalSEC ↗
Q4 202413F-HRFeb 13, 202526$1.64B canonicalSEC ↗
Q3 202413F-HRNov 13, 202426$1.38B canonicalSEC ↗
Q2 202413F-HRAug 13, 202425$352.3M canonicalSEC ↗
Q1 202413F-HRMay 14, 202426$389.9M canonicalSEC ↗